Table 2. QOLIE-31 scores at baseline and after 16 weeks of study

QOLIE-31 scores	Baseline			After 16 weeks			p-valueb
	TEA (n = 14)	STEA (n = 16)	p-valuea	TEA (n = 14)	STEA (n = 16)	p-valuea	TEA	STEA
Seizure worry	45.0 (28.7 – 53.8)	43.8 (28.7 – 53.0)	0.723	58.7 (50.0 – 71.8)	54.5 (51.0 – 65.3)	0.755	0.007	0.001
Overall quality of life	53.8 (47.5 – 67.5)	53.8 (45.0 – 67.5)	0.983	66.3 (55.0 – 67.5)	61.3 (50.0 – 67.5)	0.207	0.005	0.084
Emotional well-being	48.0 (44.0 – 64.0)	54.0 (48.0 – 64.0)	0.883	70.0 (62.0 – 76.0)	62.0 (56.0 – 68.0)	0.133	0.001	0.026
Energy/fatigue	50.0 (47.5 – 62.5)	52.5 (50.0 – 60.0)	0.933	70.0 (55.0 – 75.0)	57.5 (50.0 – 65.0)	0.085	0.005	0.046
Cognitive functioning	56.7 (48.0 – 75.3)	56.7 (48.0 – 77.3)	0.884	73.3 (63.3 – 81.3)	64.7 (54.7 – 77.3)	0.227	0.002	0.026
Medication effects	33.3 (8.3 – 56.9)	32.0 (0.0 – 66.7)	0.950	55.6 (20.8 – 72.2)	38.9 (22.2 – 66.7)	0.466	0.009	0.084
Social functioning	36.0 (24.5 – 51.0)	34.5 (22.0 – 57.0)	0.950	59.5 (36.0 – 76.0)	46.5 (37.0 – 57.0)	0.441	0.003	0.026
Overall score	48.8 (42.5 – 57.7)	44.4 (41.7 – 59.1)	0.803	65.0 (53.9 – 72.2)	57.2 (45.5 – 63.9)	0.135	0.001	0.001

Mann-Whitney U-test for comparisons of medians between TEA and STEA group
Wilcoxon signed rank-sum test for comparisons of median changes from baseline to 16 weeks in TEA group and STEA group